Fourth straight quarter of double digit growth as opportunities
present in hospital & infants markets
PainChek Ltd (ASX: PCK) (“PainChek” or “the Company”), developer of the world’s first smart device-based pain assessment and monitoring application, is pleased to announce its quarterly activities and cashflow report (Appendix 4C) for the quarter ended 30 September 2023.
Highlights
- 77,000 contracted licences with an ARR of
- $3.7M once fully implemented – 10% increase on the prior quarter and 91% increase on prior year.
- 7% quarterly increase in recognised revenue to $647,000.
- Cumulative PainChek pain assessments exceed 3,400,000 as of 30 September – an increase of 108% over the previous year.
- Three-year commercial contracts with two aged care facilities in Canada
- Uniting Care Queensland (UCQ) signs three-year contract across its 3,750 beds and 46 homes – largest Australian client to date.
- Scotland’s Care Inspectorate regulator announced PainChek in its the top three priorities in the innovation pillar of its quality improvement plan for 2023/24. A Phase 2 ‘test of change’ initiative, if successful, will support a potential national rollout across Scottish Care Homes, giving access to 38,000 licences.
- Existing pilots across 8 UK customers will provide access to a further 8,000 licences, in addition to the already contracted 20,000 licences in the UK.
- Retention rate remains at 85% of clients.
- Positive progress with the FDA de Novo study in Iowa and New York.
- Infant technology updated and ready for direct-to-consumer market introduction.
- Successfully achieved ISO 27001 certification, marking a significant milestone in PainChek’s ongoing commitment to information security and data protection.
- $3.55 million placement of shares announced, $2.83 million received in Q1, $0.72 million to be received end of November 2023.
- The Company will hold an investor webinar & Q&A for all shareholders and interested parties on Tuesday 31 October 2023 at 11:00am AEDT, further details will be available on the ASX announcements.
- Forums
- ASX - By Stock
- PCK
- Ann: Quarterly Update and Appendix 4C
Ann: Quarterly Update and Appendix 4C, page-15
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
0.001(3.70%) |
Mkt cap ! $45.80M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.8¢ | $9.308K | 332.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 473630 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 101572 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 473630 | 0.027 |
2 | 450000 | 0.026 |
4 | 1259914 | 0.025 |
6 | 889453 | 0.024 |
2 | 894565 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 101572 | 5 |
0.029 | 255804 | 3 |
0.030 | 794177 | 6 |
0.031 | 63334 | 2 |
0.032 | 25118 | 1 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online